Micron Stock Surges as UBS Flags Strong Memory Demand and Enhanced LongTerm Agreements Bloomberg Reports PepsiCo Preparing New Snack Price Increases for Late June Fed Dissenters Explain No Votes Oppose Signaling Next Rate Cut Oil Marketing Stocks Rally as Brent Crude Dips Below 98 Fuel Prices Rise for Fourth Time Block Expands Square Partnership Network Ecosystem Growth Signals Potential Upside Bessent Predicts Substantial Disinflation as Warsh Assumes Fed Leadership VRE Q4 2025 Earnings EPS Surprises to the Upside Despite Loss Stock Virtually Flat CWCO Q1 2026 Earnings Earnings Miss Estimates Despite Positive Stock Movement PSHG Q4 2025 Earnings EPS Beats Estimates as Stock Declines Despite Positive Surprise PRTS Q1 2026 Earnings EPS Surprises with 4885 Beat Stock Falls 392 RCON Q4 2025 Earnings EPS Surprise Beats Estimates Amid Revenue Uncertainty HNVR Q1 2026 Earnings Slight EPS Miss Masks Underlying Stability Cheetah Net Supply Chain Service Inc CTNT Dips 556 as Stock Tests Key Support Near 161 BristolMyers Squibb BMY Sees Modest Decline Holds Above Key Support Rising Dragon Acquisition Corp Rights RDACR Tumbles 17 as Price Nears Key Support Park National Corporation Edges Higher Key Support Levels Hold Firm Oculis Holding OCS Gains Ground as Shares Approach Key Resistance Level Amazon Expands AI Shopping Technology to ThirdParty Retailers Starting with Kate Spade CCLD Q1 2026 Earnings EPS Misses Estimates Stock Declines 34 BBVA Shares Dip 15 as Support Levels Come into Focus Mitsubishi UFJ Financial Group MUFG Q1 2026 Earnings Strong EPS Beat Driven by Higher Net Interest Income WBD Q1 2026 Earnings NarrowerThanExpected Loss Signals Progress in Turnaround NTNX Q1 2026 Earnings Strong EPS Beat Drives Stock Surge TDOC Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Turnaround Efforts First Mid Bancshares Inc FMBH Q1 2026 Earnings Strong EPS Beat Amid Quiet Market Reaction Permian Resources Corporation PR Q1 2026 Earnings Significant EPS Miss Amid Operational Headwinds PDS Biotechnology Q1 2026 Earnings EPS Beat and Clinical Progress Highlight PreRevenue Quarter